{"entity":{"id":"rv001v","kind":"drug","name":"RV001V","aka":[],"tldr":"RV001V is a cancer vaccine from RhoVac APS, in registered phase 2 trials for prostate cancer.","summary":"RV001V is listed on ClinicalTrials.gov as an intervention in 1 registered phase 2 trial sponsored by RhoVac APS, in prostate cancer. A cancer vaccine, as described in the registry record: it trains the immune system against tumour antigens. OnCo records the agent from the registry alone; approvals, results and the sponsor's own description will follow as they are published.","status":"phase-2","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov: trials of RV001V","url":"https://clinicaltrials.gov/search?intr=RV001V"}],"tags":["pipeline","ctgov-ingest","registry-only"],"related":[],"cancers":["prostate"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct04114825"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2, registry-only)","editedOn":"2026-09-16"},"code":"RV001V","modality":"Cancer vaccine","mechanism":"A cancer vaccine, as described in the registry record: it trains the immune system against tumour antigens.","approvals":[],"mechanismSteps":[],"toxicity":[],"access":[],"regulatoryEvents":[]},"route":"/drugs/rv001v/","neighbours":{"cancer":[{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"trial":[{"id":"nct04114825","kind":"trial","name":"Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer","route":"/trials/nct04114825/"}]}}